{"id":"NCT01675622","sponsor":"Mundipharma (China) Pharmaceutical Co. Ltd","briefTitle":"Immediate-Release Oxycodone Capsules Study in Cancer Pain","officialTitle":"A Comparative Study of Immediate-Release Oxycodone Capsules Versus Immediate-Release Morphine Tablets for the Treatment of Chinese Patients With Cancer Pain.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-01","primaryCompletion":"2012-06","completion":"2012-07","firstPosted":"2012-08-30","resultsPosted":"2018-05-21","lastUpdate":"2018-05-21"},"enrollment":242,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Cancer"],"interventions":[{"type":"DRUG","name":"Oxycodone","otherNames":["No other name in this study"]},{"type":"DRUG","name":"Morphine","otherNames":["No other name"]}],"arms":[{"label":"Oxycodone Capsules for cancer pain","type":"EXPERIMENTAL"},{"label":"Morphine tablets for cancer pain","type":"ACTIVE_COMPARATOR"}],"summary":"The efficacy of dose titration of OxyNormâ„¢(Oxycodone) immediate-release capsules versus morphine immediate-release tablets in the treatment of cancer pain.","primaryOutcome":{"measure":"Numerical Rating Scale (NRS)","timeFrame":"baseline up to 5-8 days (double blind period)","effectByArm":[{"arm":"Oxycodone Capsules for Cancer Pain","deltaMin":3.91,"sd":2.31},{"arm":"Morphine Tablets for Cancer Pain","deltaMin":3.87,"sd":2.22}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":120},"commonTop":["Constipation","Nausea","Vomiting","Dizziness","Fever"]}}